Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.4043
+0.0073 (1.84%)
At close: Jan 22, 2026, 4:00 PM EST
0.3950
-0.0093 (-2.30%)
After-hours: Jan 22, 2026, 6:59 PM EST
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $24.28 million as of January 22, 2026. Its market cap has decreased by -13.56% in one year.
Market Cap
24.28M
Enterprise Value
16.97M
1-Year Change
-13.56%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $24.28M, a decrease of -63.21%. That is a compound annual growth rate of -32.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 23.85M | -3.22% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IGC Pharma | 26.97M |
| Quantum BioPharma | 26.21M |
| Polyrizon | 25.49M |
| NanoViricides | 25.45M |
| Vistagen Therapeutics | 25.05M |
| LeonaBio | 24.85M |
| Klotho Neurosciences | 24.27M |
| Hyperion DeFi | 23.72M |